57 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:19pm
and enhancements and changing customer demands. As a result, an investment in the stocks of the Company is highly speculative and is only suitable
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements … :
in the event that the first sale to a retail customer does not occur on or before January 30th, 2025;
ii)
in the event that we do not target submission
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:17pm
, social security number, bank information, or customer or account number; (ii) any information which would qualify as “personally identifying
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:15pm
and product announcements, introductions and enhancements and changing customer demands. As a result, an investment in the stocks of the Company is highly
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:12pm
, introductions and enhancements and changing customer demands. As a result, an investment in the stocks of the Company is highly speculative and is only suitable
424B3
rg6l8cr le
13 Jun 24
Prospectus supplement
4:11pm
424B3
z50 jkbj6t761cm
13 Jun 24
Prospectus supplement
4:10pm
424B3
zh0a2drxk
13 Jun 24
Prospectus supplement
4:10pm
6-K
EX-99.2
atg fd8tcj2vlv7zca
16 May 24
Condensed Interim Consolidated Financial Statements
6:45pm
6-K
EX-10.1
ta4ei
30 Nov 23
XORTX Announces US ATM Offering
4:04pm
6-K
EX-99.2
4s7n agikljvq9fzmzt6
15 Nov 23
Condensed Interim Consolidated Financial Statements
9:30pm
424B3
uxkht4lwj 08
25 Aug 23
Prospectus supplement
6:00am
424B3
gilphcr7gzyw
25 Aug 23
Prospectus supplement
6:00am
6-K
EX-99.2
miadp7xol0z
15 Aug 23
Condensed Interim Consolidated Financial Statements
6:00am
6-K
EX-99.2
42vnbbmsm 6zg0610f
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am